Professor Glenn A. Okun
Exxon Mobil (XOM): UBS lowered its price target to $138 from $142 but maintained its buy rating on the stock. It asserted that Exxon is best positioned to outperform its peers during the next cycle due to its superior upstream growth potential along with its downstream and chemical capacity additions.
The Rabid Capitalist 
Leave a comment